The Efficacy of Palmitoylethanolamide (Levagen+) on the Incidence and Symptoms of Upper Respiratory Tract Infection—A Double Blind, Randomised, Placebo-Controlled Trial

Introduction: Upper respiratory tract infections (URTIs) are caused by bacteria or viruses, with the most common causes being the common cold and influenza. The high occurrence of URTI means therapies that are effective with minimal side effects are in constant demand. Palmitoylethanolamide (PEA) is...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Amanda, Skinner, Rachael, Briskey, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609976/
https://www.ncbi.nlm.nih.gov/pubmed/37892528
http://dx.doi.org/10.3390/nu15204453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609976/
https://www.ncbi.nlm.nih.gov/pubmed/37892528
http://dx.doi.org/10.3390/nu15204453

Ejemplares similares